“…These deficiencies become especially important as several MMPs, including MMP-8 and, potentially, MMP-19 and MMP-25, demonstrate anti-tumor properties and thus should not be pharmacologically targeted in certain malignancies while the function of multiple additional MMPs remains unknown in disease context (Chernov, et al, 2010; Chernov and Strongin, 2011; Coussens, et al, 2002; Gutierrez-Fernandez, et al, 2008; Overall and Kleifeld, 2006; Shay, et al, 2015). Precise knowledge of the MMP cleavage preferences is needed to rationally relate MMPs to the cleaved substrates.…”